Two separate reports sound alarm on PBM practices that harm patients, consumers
Consumers should be alarmed by two independent reports that accuse pharmacy benefit managers, the influential middlemen in our health care system, of deploying anticompetitive pricing tactics that jeopardize patient care and undermine local pharmacies. The reports by the Federal Trade Commission and U.S. House Committee on Oversight and Accountability echoed concerns long voiced by consumers, doctors, pharmacists […]